These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Analysis of the immune microenvironment in resected non-small cell lung cancer: the prognostic value of different T lymphocyte markers. Usó M; Jantus-Lewintre E; Bremnes RM; Calabuig S; Blasco A; Pastor E; Borreda I; Molina-Pinelo S; Paz-Ares L; Guijarro R; Martorell M; Forteza J; Camps C; Sirera R Oncotarget; 2016 Aug; 7(33):52849-52861. PubMed ID: 27463005 [TBL] [Abstract][Full Text] [Related]
4. Exosomes isolation and characterization in serum is feasible in non-small cell lung cancer patients: critical analysis of evidence and potential role in clinical practice. Taverna S; Giallombardo M; Gil-Bazo I; Carreca AP; Castiglia M; Chacártegui J; Araujo A; Alessandro R; Pauwels P; Peeters M; Rolfo C Oncotarget; 2016 May; 7(19):28748-60. PubMed ID: 26919248 [TBL] [Abstract][Full Text] [Related]
5. Validation of a reverse transcription-polymerase chain reaction-based five-gene signature in non-small cell lung cancer. Ruco L; Scarpino S; Natoli G J Thorac Oncol; 2009 May; 4(5):670. PubMed ID: 19395916 [No Abstract] [Full Text] [Related]
6. Clinical implication of microrna for lung cancer. Wang Y; Zhang X; Liu L; Li H; Yu J; Wang C; Ren X Cancer Biother Radiopharm; 2013 May; 28(4):261-7. PubMed ID: 23496233 [TBL] [Abstract][Full Text] [Related]
7. Invited commentary. Lee HS; Zo JI Ann Thorac Surg; 2012 May; 93(5):1613. PubMed ID: 22541191 [No Abstract] [Full Text] [Related]
8. Genetic polymorphisms and non-small-cell lung cancer: future paradigms. de Mello RA Einstein (Sao Paulo); 2014; 12(4):524-6. PubMed ID: 25628210 [TBL] [Abstract][Full Text] [Related]
9. The hypoxic tumor microenvironment: driving the tumorigenesis of non-small-cell lung cancer. Foster JG; Wong SC; Sharp TV Future Oncol; 2014 Dec; 10(16):2659-74. PubMed ID: 25531051 [TBL] [Abstract][Full Text] [Related]
13. Morphology and a limited number of immunohistochemical markers may efficiently subtype non-small-cell lung cancer. Rossi G; Papotti M; Barbareschi M; Graziano P; Pelosi G J Clin Oncol; 2009 Oct; 27(28):e141-2; author reply e143-4. PubMed ID: 19720885 [No Abstract] [Full Text] [Related]
14. The spatial transcriptomic landscape of non-small cell lung cancer brain metastasis. Zhang Q; Abdo R; Iosef C; Kaneko T; Cecchini M; Han VK; Li SS Nat Commun; 2022 Oct; 13(1):5983. PubMed ID: 36216799 [TBL] [Abstract][Full Text] [Related]
15. Application of clinical bioinformatics in lung cancer-specific biomarkers. Wu D; Wang X Cancer Metastasis Rev; 2015 Jun; 34(2):209-16. PubMed ID: 25933723 [TBL] [Abstract][Full Text] [Related]
16. Molecular diagnostics in advanced NSCLC: trying to maximize a non-ideal situation. Lim EH; Tan P J Thorac Oncol; 2007 Aug; 2(8):782. PubMed ID: 17762350 [No Abstract] [Full Text] [Related]
17. MicroRNA-1976 functions as a tumor suppressor and serves as a prognostic indicator in non-small cell lung cancer by directly targeting PLCE1. Chen G; Hu J; Huang Z; Yang L; Chen M Biochem Biophys Res Commun; 2016 May; 473(4):1144-1151. PubMed ID: 27063799 [TBL] [Abstract][Full Text] [Related]
19. AKR1B10 is associated with smoking and smoking-related non-small-cell lung cancer. Kang MW; Lee ES; Yoon SY; Jo J; Lee J; Kim HK; Choi YS; Kim K; Shim YM; Kim J; Kim H J Int Med Res; 2011; 39(1):78-85. PubMed ID: 21672310 [TBL] [Abstract][Full Text] [Related]
20. Combined analysis identifies six genes correlated with augmented malignancy from non-small cell to small cell lung cancer. Zhang C; Min L; Zhang L; Ma Y; Yang Y; Shou C Tumour Biol; 2016 Feb; 37(2):2193-207. PubMed ID: 26349752 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]